Published in Glia on December 01, 2006
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat Commun (2015) 1.57
Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol (2013) 1.43
Neuroinflammation in Huntington's disease. J Neural Transm (Vienna) (2010) 1.16
Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem (2011) 1.16
Oligodendrocyte fate after spinal cord injury. Neurotherapeutics (2011) 1.09
A possible role for secreted ferritin in tissue iron distribution. J Neural Transm (Vienna) (2011) 0.96
Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci (2012) 0.94
Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol (2009) 0.91
Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1. J Neuroinflammation (2009) 0.89
Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology (2010) 0.87
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases. Front Cell Neurosci (2013) 0.85
Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci (2011) 0.85
Iron chelation and multiple sclerosis. ASN Neuro (2014) 0.84
Iron localization in superficial siderosis of the central nervous system. Neuropathology (2008) 0.82
Neonatal E. coli infection causes neuro-behavioral deficits associated with hypomyelination and neuronal sequestration of iron. J Neurosci (2013) 0.82
Dietary factors in the etiology of Parkinson's disease. Biomed Res Int (2015) 0.81
Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls. Toxicol Sci (2015) 0.80
Glial cell activity is maintained during prolonged inflammatory challenge in rats. Braz J Med Biol Res (2012) 0.79
Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage. Mol Neurobiol (2016) 0.79
Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within? Curr Neuropharmacol (2016) 0.79
Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage. Exp Neurol (2014) 0.79
Microglia: Architects of the Developing Nervous System. Trends Cell Biol (2016) 0.78
Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair. Front Cell Dev Biol (2016) 0.77
The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability. Sci Rep (2015) 0.76
The conundrum of iron in multiple sclerosis--time for an individualised approach. Metab Brain Dis (2012) 0.76
Regulation of divalent metal transporter-1 by serine phosphorylation. Biochem J (2016) 0.75
Evolution, immunity and the emergence of brain superautoantigens. F1000Res (2017) 0.75
Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals. Neuroimage Clin (2017) 0.75
Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value. PLoS One (2017) 0.75
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A (1988) 2.57
Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem (1996) 2.33
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology (2008) 2.21
Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. J Bone Miner Res (1995) 2.01
Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res (1999) 1.86
Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. Clin Cancer Res (1999) 1.84
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology (2000) 1.75
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem (1995) 1.65
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res (1997) 1.63
Iron in the brain. Nutr Rev (1993) 1.58
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem J (1992) 1.58
Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res (2004) 1.57
Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res (1987) 1.51
Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia (2001) 1.51
Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J Nutr (1997) 1.45
Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum (1998) 1.44
The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J Mol Biol (1994) 1.43
Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem (1993) 1.43
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res (2001) 1.38
Expression and structural and functional properties of human ferritin L-chain from Escherichia coli. Biochemistry (1989) 1.34
Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts. Proc Natl Acad Sci U S A (1988) 1.29
Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol Cell Physiol (2007) 1.29
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci (2001) 1.27
Evidence that residues exposed on the three-fold channels have active roles in the mechanism of ferritin iron incorporation. Biochem J (1996) 1.26
Insight into the pathophysiology of restless legs syndrome. J Neurosci Res (2000) 1.26
Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia. Osteoarthritis Cartilage (2006) 1.26
Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res (1997) 1.22
Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum (2000) 1.19
Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol (1999) 1.18
Viruses and the versatile macrophage. Br Med Bull (1985) 1.15
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem (1999) 1.14
Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Neuroscience (2003) 1.14
Functional and immunological analysis of recombinant mouse H- and L-ferritins from Escherichia coli. Protein Expr Purif (2000) 1.13
NPC 15669 inhibits the reversed passive Arthus reaction in rats by blocking neutrophil recruitment. J Pharmacol Exp Ther (1992) 1.12
Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain. J Neural Transm Suppl (2006) 1.12
Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol (1998) 1.11
Variations in dietary iron alter brain iron metabolism in developing rats. J Nutr (2000) 1.11
Do oligodendrocytes mediate iron regulation in the human brain? Ann Neurol (1989) 1.10
N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action. Proc Natl Acad Sci U S A (1991) 1.08
Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res (1999) 1.08
Iron and neurodegenerative disorders. Brain Res Bull (2001) 1.08
Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res (1998) 1.08
Identification of the EPR-active iron-nitrosyl complexes in mammalian ferritins. Biochemistry (1994) 1.06
Iron, transferrin, and ferritin in the rat brain during development and aging. J Neurochem (1994) 1.06
Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience (1999) 1.03
Identification and initial characterization of 5000 expressed sequenced tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA libraries. Osteoarthritis Cartilage (2001) 1.02
Iron up-modulates the expression of transferrin receptors during monocyte-macrophage maturation. J Biol Chem (1989) 1.02
Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta (2000) 1.01
Evidence that the specificity of iron incorporation into homopolymers of human ferritin L- and H-chains is conferred by the nucleation and ferroxidase centres. Biochem J (1996) 0.99
Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ (2001) 0.99
Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol (1993) 0.99
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience (2001) 0.99
The distribution of transferrin immunoreactivity in the rat central nervous system. Brain Res (1986) 0.98
Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience (2004) 0.97
Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res (1999) 0.97
Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms. Neuropharmacology (1999) 0.97
The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine. Mol Psychiatry (2001) 0.96
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus. Neuropharmacology (2005) 0.96
CKbeta-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J Cell Physiol (2000) 0.95
VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme. Mol Med (2001) 0.95
Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J Neurosci Res (2000) 0.95
1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia. Eur J Neurosci (1999) 0.95
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. J Bone Miner Res (2001) 0.94
Aluminum access to the brain: a role for transferrin and its receptor. Proc Natl Acad Sci U S A (1990) 0.94
2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain. Mol Pharmacol (1992) 0.94
Transferrin is required for normal distribution of 59Fe and 54Mn in mouse brain. J Neurol Sci (1999) 0.93
Distribution of injected iron 59 and manganese 54 in hypotransferrinemic mice. J Lab Clin Med (1996) 0.93
Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum (1999) 0.93
Hypoxia-inducible factor pathway activation in restless legs syndrome patients. Eur J Neurol (2011) 0.92
Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim Biophys Acta (2000) 0.91
Construction of a ferroxidase center in human ferritin L-chain. J Biol Chem (1994) 0.91
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms. J Med Chem (1996) 0.90
The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther (1997) 0.89
cDNA cloning by amplification of circularized first strand cDNAs reveals non-IRE-regulated iron-responsive mRNAs. Biochem Biophys Res Commun (2000) 0.89
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. Br J Pharmacol (2012) 0.89
The soluble form of E-selectin is an asymmetric monomer. Expression, purification, and characterization of the recombinant protein. J Biol Chem (1994) 0.88
Inhibition of IFN-gamma-induced Ia antigen expression on synovial fibroblasts by IL-1. J Immunol (1989) 0.88
Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci (1999) 0.88
Biochemical characteristics of dissociatively isolated aortic proteoglycans and their binding capacity to hyaluronic acid. J Biol Chem (1983) 0.88
Interleukin 1 stimulates prostaglandin synthesis and cyclic AMP accumulation in Swiss 3T3 fibroblasts: interactions between two second messenger systems. J Cell Physiol (1989) 0.88
Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res (2000) 0.88
Effects of modifications near the 2-, 3- and 4-fold symmetry axes on human ferritin renaturation. Biochem J (1997) 0.87
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype. FEBS Lett (1999) 0.87
Iron deficiency alters H- and L-ferritin expression in rat brain. Cell Mol Biol (Noisy-le-grand) (2000) 0.87
Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage (2000) 0.87
Mechanisms of regulation of ferritin synthesis in rat liver during experimental inflammation. Exp Mol Pathol (1988) 0.87
Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor. Osteoarthritis Cartilage (1999) 0.87
A comparison of dendritic spine number and type on pyramidal neurons of the visual cortex of old adult rats from social or isolated environments. J Comp Neurol (1982) 0.86
Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains. Cell Mol Biol (Noisy-le-grand) (2000) 0.86
Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia. Adv Exp Med Biol (1999) 0.86
The kallikrein-kininogen-kinin system in chronic inflammation. Agents Actions (1989) 0.86
Human serum ferritin G-peptide is recognized by anti-L ferritin subunit antibodies and concanavalin-A. Br J Haematol (1987) 0.86
Expression of transferrin mRNA in the CNS of normal and jimpy mice. J Neurochem (1991) 0.85
Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains. Neuroscience (1997) 0.85
FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosis. Osteoarthritis Cartilage (2000) 0.85
Brain iron, transferrin and ferritin concentrations are altered in developing iron-deficient rats. J Nutr (1995) 0.85
A demonstration of glial filament distribution in astrocytes isolated from rat cerebral cortex. Neuroscience (1985) 0.85
D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II. Peptides (1989) 0.85